{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:37:57Z","timestamp":1793828277874,"version":"4.6.1"},"reference-count":303,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fresco Institute for Parkinson's and Movement Disorders","award":["not available"],"award-info":[{"award-number":["not available"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12035-020-01926-1","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:03:21Z","timestamp":1590138201000},"page":"2959-2980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":367,"title":["The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer\u2019s Disease and Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-8766","authenticated-orcid":false,"given":"Giacomo","family":"Monzio Compagnoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Di Fonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"crossref","unstructured":"Erkkinen MG, Kim MO, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10(4).","DOI":"10.1101\/cshperspect.a033118"},{"issue":"7483","key":"1926_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman JR, Nunnari J (2014) Mitochondrial form and function. Nature. 505(7483):335\u2013343","journal-title":"Nature."},{"issue":"26","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","volume":"348","author":"S DiMauro","year":"2003","unstructured":"DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348(26):2656\u20132668","journal-title":"N Engl J Med"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR et al (2016) Mitochondrial diseases. Nat Rev Dis Primers 2:16080","journal-title":"Nat Rev Dis Primers"},{"issue":"5407","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace DC (1999) Mitochondrial diseases in man and mouse. Science. 283(5407):1482\u20131488","journal-title":"Science."},{"key":"1926_CR6","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL (2015) Alzheimer\u2019s disease. Nat Rev Dis Primers 1:15056","journal-title":"Nat Rev Dis Primers"},{"issue":"10043","key":"1926_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer\u2019s disease. Lancet. 388(10043):505\u2013517","journal-title":"Lancet."},{"issue":"2","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741\u2013766","journal-title":"Physiol Rev"},{"issue":"5580","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297(5580):353\u2013356","journal-title":"Science."},{"issue":"3","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/JAD-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH (2018) Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis 62(3):1403\u20131416","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 2","key":"1926_CR11","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(Suppl 2):S265\u2013S279","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1926_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0197-4580(80)90005-6","volume":"1","author":"SH Ferris","year":"1980","unstructured":"Ferris SH, de Leon MJ, Wolf AP, Farkas T, Christman DR, Reisberg B, Fowler JS, Macgregor R et al (1980) Positron emission tomography in the study of aging and senile dementia. Neurobiol Aging 1(2):127\u2013131","journal-title":"Neurobiol Aging"},{"issue":"8","key":"1926_CR13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1212\/WNL.33.8.961","volume":"33","author":"NL Foster","year":"1983","unstructured":"Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G (1983) Alzheimer\u2019s disease: focal cortical changes shown by positron emission tomography. Neurology. 33(8):961\u2013965","journal-title":"Neurology."},{"issue":"4","key":"1926_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH et al (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 7(4):590\u2013598","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"1926_CR15","first-page":"568","volume":"4","author":"MJ de Leon","year":"1983","unstructured":"de Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B et al (1983) Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol 4(3):568\u2013571","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1926_CR16","first-page":"143","volume":"4","author":"S Shokouhi","year":"2014","unstructured":"Shokouhi S, Claassen D, Riddle W (2014) Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography. J Alzheimers Dis Parkinsonism 4(2):143","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"Pt 4","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/brain\/104.4.753","volume":"104","author":"RS Frackowiak","year":"1981","unstructured":"Frackowiak RS, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, Jones T (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain. 104(Pt 4):753\u2013778","journal-title":"Brain."},{"issue":"1","key":"1926_CR18","first-page":"1","volume":"35","author":"H Fukuyama","year":"1994","unstructured":"Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994) Altered cerebral energy metabolism in Alzheimer\u2019s disease: a PET study. J Nucl Med 35(1):1\u20136","journal-title":"J Nucl Med"},{"issue":"7","key":"1926_CR19","first-page":"1159","volume":"37","author":"K Ishii","year":"1996","unstructured":"Ishii K, Kitagaki H, Kono M, Mori E (1996) Decreased medial temporal oxygen metabolism in Alzheimer\u2019s disease shown by PET. J Nucl Med 37(7):1159\u20131165","journal-title":"J Nucl Med"},{"issue":"3","key":"1926_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s002340050553","volume":"40","author":"H Tohgi","year":"1998","unstructured":"Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, Hatano K, Sasaki T (1998) Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer\u2019s type and vascular dementia with deep white matter changes. Neuroradiology. 40(3):131\u2013137","journal-title":"Neuroradiology."},{"issue":"2","key":"1926_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/JAD-2006-9204","volume":"9","author":"SJ Baloyannis","year":"2006","unstructured":"Baloyannis SJ (2006) Mitochondrial alterations in Alzheimer\u2019s disease. J Alzheimers Dis 9(2):119\u2013126","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1926_CR22","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y et al (2001) Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 21(9):3017\u20133023","journal-title":"J Neurosci"},{"key":"1926_CR23","doi-asserted-by":"publisher","first-page":"18725","DOI":"10.1038\/srep18725","volume":"6","author":"L Zhang","year":"2016","unstructured":"Zhang L, Trushin S, Christensen TA, Bachmeier BV, Gateno B, Schroeder A, Yao J, Itoh K et al (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer\u2019s disease. Sci Rep 6:18725","journal-title":"Sci Rep"},{"issue":"8","key":"1926_CR24","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","volume":"45","author":"GE Gibson","year":"1988","unstructured":"Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease. Arch Neurol 45(8):836\u2013840","journal-title":"Arch Neurol"},{"issue":"1","key":"1926_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3940(80)90220-7","volume":"18","author":"EK Perry","year":"1980","unstructured":"Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A-acetylating enzymes in Alzheimer\u2019s disease: possible cholinergic \u2018compartment\u2019 of pyruvate dehydrogenase. Neurosci Lett 18(1):105\u2013110","journal-title":"Neurosci Lett"},{"issue":"1","key":"1926_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ana.410130116","volume":"13","author":"S Sorbi","year":"1983","unstructured":"Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13(1):72\u201378","journal-title":"Ann Neurol"},{"issue":"8","key":"1926_CR27","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","volume":"40","author":"WD Parker Jr","year":"1990","unstructured":"Parker WD Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer\u2019s disease. Neurology. 40(8):1302\u20131303","journal-title":"Neurology."},{"issue":"1","key":"1926_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","volume":"25","author":"SM Cardoso","year":"2004","unstructured":"Cardoso SM, Proen\u00e7a MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer\u2019s disease platelets. Neurobiol Aging 25(1):105\u2013110","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1926_CR29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","volume":"44","author":"WD Parker Jr","year":"1994","unstructured":"Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK (1994) Electron transport chain defects in Alzheimer\u2019s disease brain. Neurology. 44(6):1090\u20131096","journal-title":"Neurology."},{"issue":"2","key":"1926_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM et al (1992) Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem 59(2):776\u2013779","journal-title":"J Neurochem"},{"issue":"3","key":"1926_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM et al (2019) Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22(3):401\u2013412","journal-title":"Nat Neurosci"},{"issue":"3","key":"1926_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, Fang EF (2017) Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms. Trends Neurosci 40(3):151\u2013166","journal-title":"Trends Neurosci"},{"key":"1926_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fnmol.2017.00291","volume":"10","author":"P Mart\u00edn-Maestro","year":"2017","unstructured":"Mart\u00edn-Maestro P, Gargini RA, Sproul A, Garc\u00eda E, Ant\u00f3n LC, Noggle S, Arancio O, Avila J et al (2017) Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer\u2019s disease-associated presenilin 1 Mutation. Front Mol Neurosci 10:291","journal-title":"Front Mol Neurosci"},{"issue":"10","key":"1926_CR34","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","volume":"24","author":"X Ye","year":"2015","unstructured":"Ye X, Sun X, Starovoytov V, Cai Q (2015) Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer\u2019s disease patient brains. Hum Mol Genet 24(10):2938\u20132951","journal-title":"Hum Mol Genet"},{"issue":"11","key":"1926_CR35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","volume":"1847","author":"MJ Keogh","year":"2015","unstructured":"Keogh MJ, Chinnery PF (2015) Mitochondrial DNA mutations in neurodegeneration. Biochim Biophys Acta 1847(11):1401\u20131411","journal-title":"Biochim Biophys Acta"},{"issue":"29","key":"1926_CR36","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1073\/pnas.0403649101","volume":"101","author":"PE Coskun","year":"2004","unstructured":"Coskun PE, Beal MF, Wallace DC (2004) Alzheimer\u2019s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A 101(29):10726\u201310731","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"1926_CR37","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","volume":"20","author":"PE Coskun","year":"2010","unstructured":"Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW et al (2010) Systemic mitochondrial dysfunction and the etiology of Alzheimer\u2019s disease and down syndrome dementia. J Alzheimers Dis 20(Suppl 2):S293\u2013S310","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1926_CR38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23955","volume":"74","author":"P Podlesniy","year":"2013","unstructured":"Podlesniy P, Figueiro-Silva J, Llado A, Antonell A, Sanchez-Valle R, Alcolea D, Lleo A, Molinuevo JL et al (2013) Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol 74(5):655\u2013668","journal-title":"Ann Neurol"},{"issue":"2","key":"1926_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-131715","volume":"40","author":"AC Rice","year":"2014","unstructured":"Rice AC, Keeney PM, Algarzae NK, Ladd AC, Thomas RR, Bennett JP Jr (2014) Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer\u2019s disease hippocampi. J Alzheimers Dis 40(2):319\u2013330","journal-title":"J Alzheimers Dis"},{"key":"1926_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40478-016-0404-6","volume":"5","author":"W Wei","year":"2017","unstructured":"Wei W, Keogh MJ, Wilson I, Coxhead J, Ryan S, Rollinson S, Griffin H, Kurzawa-Akinibi M et al (2017) Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathol Commun 5:13","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1926_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2004.04.051","volume":"365","author":"JM van der Walt","year":"2004","unstructured":"van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM et al (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365(1):28\u201332","journal-title":"Neurosci Lett"},{"issue":"8","key":"1926_CR42","doi-asserted-by":"publisher","first-page":"e12037","DOI":"10.1371\/journal.pone.0012037","volume":"5","author":"A Santoro","year":"2010","unstructured":"Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, Tavano F, Achilli A, Siviero P et al (2010) Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer\u2019s disease. PLoS One 5(8):e12037","journal-title":"PLoS One"},{"issue":"8","key":"1926_CR43","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.neurobiolaging.2010.04.031","volume":"31","author":"A Lakatos","year":"2010","unstructured":"Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G et al (2010) Alzheimer\u2019s disease neuroimaging initiative. Association between mitochondrial DNA variations and Alzheimer\u2019s disease in the ADNI cohort. Neurobiol Aging 31(8):1355\u20131363","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1926_CR44","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.neurobiolaging.2008.01.004","volume":"30","author":"A Maruszak","year":"2009","unstructured":"Maruszak A, Canter JA, Styczy\u0144ska M, Zekanowski C, Barcikowska M (2009) Mitochondrial haplogroup H and Alzheimer\u2019s disease--is there a connection? Neurobiol Aging 30(11):1749\u20131755","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1926_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00439-005-0123-8","volume":"119","author":"JL Elson","year":"2006","unstructured":"Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM et al (2006) Does the mitochondrial genome play a role in the etiology of Alzheimer\u2019s disease? Hum Genet 119(3):241\u2013254","journal-title":"Hum Genet"},{"key":"1926_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-5-8","volume":"5","author":"J Kr\u00fcger","year":"2010","unstructured":"Kr\u00fcger J, Hinttala R, Majamaa K, Remes AM (2010) Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration. Mol Neurodegener 5:8","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1926_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10072-007-0807-z","volume":"28","author":"M Mancuso","year":"2007","unstructured":"Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, Giglioli NJ, Petrozzi L, Rossi C et al (2007) Lack of association between mtDNA haplogroups and Alzheimer\u2019s disease in Tuscany. Neurol Sci 28(3):142\u2013147","journal-title":"Neurol Sci"},{"issue":"1","key":"1926_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K","volume":"85","author":"P Chagnon","year":"1999","unstructured":"Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, Gauvreau D (1999) Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85(1):20\u201330","journal-title":"Am J Med Genet"},{"issue":"9","key":"1926_CR49","doi-asserted-by":"publisher","first-page":"e45134","DOI":"10.1371\/journal.pone.0045134","volume":"7","author":"PG Ridge","year":"2012","unstructured":"Ridge PG, Maxwell TJ, Corcoran CD, Norton MC, Tschanz JT, O'Brien E, Kerber RA, Cawthon RM et al (2012) Mitochondrial genomic analysis of late onset Alzheimer\u2019s disease reveals protective haplogroups H6A1A\/H6A1B: the Cache County study on memory in aging. PLoS One 7(9):e45134","journal-title":"PLoS One"},{"issue":"1","key":"1926_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/geno.1993.1299","volume":"17","author":"JM Shoffner","year":"1993","unstructured":"Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC et al (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 17(1):171\u2013184","journal-title":"Genomics."},{"issue":"4","key":"1926_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2990.1997.tb01301.x","volume":"23","author":"R Egensperger","year":"1997","unstructured":"Egensperger R, K\u00f6sel S, Schnopp NM, Mehraein P, Graeber MB (1997) Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer\u2019s and Parkinson\u2019s diseases. Neuropathol Appl Neurobiol 23(4):315\u2013321","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"15","key":"1926_CR52","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1073\/pnas.92.15.6892","volume":"92","author":"T Hutchin","year":"1995","unstructured":"Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci U S A 92(15):6892\u20136895","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1926_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000064955","volume":"48","author":"JR Garc\u00eda-Lozano","year":"2002","unstructured":"Garc\u00eda-Lozano JR, Mir P, Alberca R, Aguilera I, Gil N\u00e9ciga E, Fern\u00e1ndez-L\u00f3pez O, Cayuela A, N\u00fa\u00f1ez-Roldan A (2002) Mitochondrial DNA A4336G mutation in Alzheimer\u2019s and Parkinson\u2019s diseases. Eur Neurol 48(1):34\u201336","journal-title":"Eur Neurol"},{"issue":"2","key":"1926_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3940(95)12146-3","volume":"201","author":"MA Wragg","year":"1995","unstructured":"Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM (1995) No association found between Alzheimer\u2019s disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 201(2):107\u2013110","journal-title":"Neurosci Lett"},{"issue":"2","key":"1926_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/geno.1994.1525","volume":"23","author":"M Corral-Debrinski","year":"1994","unstructured":"Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23(2):471\u2013476","journal-title":"Genomics"},{"issue":"2","key":"1926_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0027-5107(97)00158-9","volume":"379","author":"NS Hamblet","year":"1997","unstructured":"Hamblet NS, Castora FJ (1997) Elevated levels of the Kearns-Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer\u2019s patients. Mutat Res 379(2):253\u2013262","journal-title":"Mutat Res"},{"issue":"1","key":"1926_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/bbrc.2000.2885","volume":"273","author":"SW Chang","year":"2000","unstructured":"Chang SW, Zhang D, Chung HD, Zassenhaus HP (2000) The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer\u2019s brain. Biochem Biophys Res Commun 273(1):203\u2013208","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1926_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2003.11.073","volume":"357","author":"C Mawrin","year":"2004","unstructured":"Mawrin C, Kirches E, Krause G, Schneider-Stock R, Bogerts B, Vorwerk CK, Dietzmann K (2004) Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans. Neurosci Lett 357(2):111\u2013114","journal-title":"Neurosci Lett"},{"issue":"2","key":"1926_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/hmg\/11.2.133","volume":"11","author":"MT Lin","year":"2002","unstructured":"Lin MT, Simon DK, Ahn CH, Kim LM, Beal MF (2002) High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer\u2019s disease brain. Hum Mol Genet 11(2):133\u2013145","journal-title":"Hum Mol Genet"},{"issue":"14","key":"1926_CR60","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1212\/WNL.0b013e31824e8f1d","volume":"78","author":"G Hudson","year":"2012","unstructured":"Hudson G, Sims R, Harold D, Chapman J, Hollingworth P, Gerrish A, Russo G, Hamshere M et al (2012) GERAD1 consortium. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology. 78(14):1038\u20131042","journal-title":"Neurology."},{"issue":"1","key":"1926_CR61","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1212\/WNL.47.1.254","volume":"47","author":"SD Edland","year":"1996","unstructured":"Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC (1996) Increased risk of dementia in mothers of Alzheimer\u2019s disease cases: evidence for maternal inheritance. Neurology. 47(1):254\u2013256","journal-title":"Neurology."},{"issue":"48","key":"1926_CR62","doi-asserted-by":"publisher","first-page":"19067","DOI":"10.1073\/pnas.0705036104","volume":"104","author":"L Mosconi","year":"2007","unstructured":"Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S et al (2007) Maternal family history of Alzheimer\u2019s disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104(48):19067\u201319072","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1926_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1212\/WNL.0b013e3181c918cb","volume":"74","author":"RA Honea","year":"2010","unstructured":"Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM (2010) Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology. 74(2):113\u2013120","journal-title":"Neurology."},{"issue":"13","key":"1926_CR64","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1073\/pnas.0914141107","volume":"107","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N et al (2010) Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer\u2019s. Proc Natl Acad Sci U S A 107(13):5949\u20135954","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1926_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbr.2004.01.016","volume":"154","author":"T Szabados","year":"2004","unstructured":"Szabados T, Dul C, Majt\u00e9nyi K, Hargitai J, P\u00e9nzes Z, Urbanics R (2004) A chronic Alzheimer\u2019s model evoked by mitochondrial poison sodium azide for pharmacological investigations. Behav Brain Res 154(1):31\u201340","journal-title":"Behav Brain Res"},{"issue":"4","key":"1926_CR66","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1471-4159.2005.03493.x","volume":"95","author":"GU H\u00f6glinger","year":"2005","unstructured":"H\u00f6glinger GU, Lannuzel A, Khondiker ME, Michel PP, Duyckaerts C, F\u00e9ger J, Champy P, Prigent A et al (2005) The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 95(4):930\u2013939","journal-title":"J Neurochem"},{"issue":"29","key":"1926_CR67","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1523\/JNEUROSCI.1644-07.2007","volume":"27","author":"M Escobar-Khondiker","year":"2007","unstructured":"Escobar-Khondiker M, H\u00f6llerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, Yamada ES et al (2007) Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci 27(29):7827\u20137837","journal-title":"J Neurosci"},{"issue":"18","key":"1926_CR68","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269(18):13623\u201313628","journal-title":"J Biol Chem"},{"issue":"2","key":"1926_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-3940(97)00536-3","volume":"231","author":"L Gasparini","year":"1997","unstructured":"Gasparini L, Racchi M, Benussi L, Curti D, Binetti G, Bianchetti A, Trabucchi M, Govoni S (1997) Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci Lett 231(2):113\u2013117","journal-title":"Neurosci Lett"},{"key":"1926_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-9-16","volume":"9","author":"L Kukreja","year":"2014","unstructured":"Kukreja L, Kujoth GC, Prolla TA, Van Leuven F, Vassar R (2014) Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP\/Ld transgenic mouse model of Alzheimer\u2019s disease. Mol Neurodegener 9:16","journal-title":"Mol Neurodegener"},{"issue":"12","key":"1926_CR71","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1523\/JNEUROSCI.17-12-04612.1997","volume":"17","author":"JP Sheehan","year":"1997","unstructured":"Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, Parker WD, Tuttle JB (1997) Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer\u2019s disease. J Neurosci 17(12):4612\u20134622","journal-title":"J Neurosci"},{"issue":"4","key":"1926_CR72","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1212\/WNL.49.4.918","volume":"49","author":"RH Swerdlow","year":"1997","unstructured":"Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP Jr, Davis RE, Parker WD Jr (1997) Cybrids in Alzheimer\u2019s disease: a cellular model of the disease? Neurology. 49(4):918\u2013925","journal-title":"Neurology."},{"issue":"2","key":"1926_CR73","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7","volume":"48","author":"SM Khan","year":"2000","unstructured":"Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC et al (2000) Alzheimer\u2019s disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol 48(2):148\u2013155","journal-title":"Ann Neurol"},{"key":"1926_CR74","doi-asserted-by":"crossref","unstructured":"Silva DF, Selfridge JE, Lu J, E L, Roy N, Hutfles L, Burns JM, Michaelis EK, Yan S, Cardoso SM, Swerdlow RH. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet 2013;22(19):3931\u20133946.","DOI":"10.1093\/hmg\/ddt247"},{"issue":"1","key":"1926_CR75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/WNL.51.1.326","volume":"51","author":"EA Schon","year":"1998","unstructured":"Schon EA, Shoubridge EA, Moraes CT (1998) Cybrids in Alzheimer\u2019s disease: a cellular model of the disease? Neurology. 51(1):326\u2013327","journal-title":"Neurology."},{"issue":"3","key":"1926_CR76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","volume":"10","author":"E Tamagno","year":"2002","unstructured":"Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O et al (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10(3):279\u2013288","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1926_CR77","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00001756-199806010-00015","volume":"9","author":"C Pereira","year":"1998","unstructured":"Pereira C, Santos MS, Oliveira C (1998) Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport. 9(8):1749\u20131755","journal-title":"Neuroreport."},{"issue":"1","key":"1926_CR78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-5793(99)01028-5","volume":"457","author":"L Canevari","year":"1999","unstructured":"Canevari L, Clark JB, Bates TE (1999) Beta-amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett 457(1):131\u2013134","journal-title":"FEBS Lett"},{"issue":"3","key":"1926_CR79","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","volume":"25","author":"PJ Crouch","year":"2005","unstructured":"Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA et al (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 25(3):672\u2013679","journal-title":"J Neurosci"},{"issue":"8","key":"1926_CR80","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1096\/fj.00-0561fje","volume":"15","author":"SM Cardoso","year":"2001","unstructured":"Cardoso SM, Santos S, Swerdlow RH, Oliveira CR (2001) Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J 15(8):1439\u20131441","journal-title":"FASEB J"},{"issue":"35","key":"1926_CR81","doi-asserted-by":"publisher","first-page":"14163","DOI":"10.1073\/pnas.0705738104","volume":"104","author":"H Fukui","year":"2007","unstructured":"Fukui H, Diaz F, Garcia S, Moraes CT (2007) Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 104(35):14163\u201314168","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"1926_CR82","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29(28):9090\u20139103","journal-title":"J Neurosci"},{"issue":"2","key":"1926_CR83","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","volume":"173","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Fujioka H, Zhu X (2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer\u2019s disease patients. Am J Pathol 173(2):470\u2013482","journal-title":"Am J Pathol"},{"issue":"49","key":"1926_CR84","doi-asserted-by":"publisher","first-page":"19318","DOI":"10.1073\/pnas.0804871105","volume":"105","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins. Proc Natl Acad Sci U S A 105(49):19318\u201319323","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"1926_CR85","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 20(13):2495\u20132509","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1926_CR86","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2174\/1567205013666151221145445","volume":"13","author":"JS Beck","year":"2016","unstructured":"Beck JS, Mufson EJ, Counts SE (2016) Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer\u2019s disease. Curr Alzheimer Res 13(6):610\u2013614","journal-title":"Curr Alzheimer Res"},{"issue":"7684","key":"1926_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature25143","volume":"552","author":"V Sorrentino","year":"2017","unstructured":"Sorrentino V, Romani M, Mouchiroud L, Beck JS, Zhang H, D'Amico D, Moullan N, Potenza F et al (2017) Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity. Nature. 552(7684):187\u2013193","journal-title":"Nature."},{"issue":"14","key":"1926_CR88","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","volume":"19","author":"C Caspersen","year":"2005","unstructured":"Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D et al (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease. FASEB J 19(14):2040\u20132041","journal-title":"FASEB J"},{"issue":"Suppl 2","key":"1926_CR89","doi-asserted-by":"publisher","first-page":"S569","DOI":"10.3233\/JAD-2010-100357","volume":"20","author":"JX Chen","year":"2010","unstructured":"Chen JX, Yan SS (2010) Role of mitochondrial amyloid-beta in Alzheimer\u2019s disease. J Alzheimers Dis 20(Suppl 2):S569\u2013S578","journal-title":"J Alzheimers Dis"},{"issue":"35","key":"1926_CR90","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","volume":"26","author":"L Devi","year":"2006","unstructured":"Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain is associated with mitochondrial dysfunction. J Neurosci 26(35):9057\u20139068","journal-title":"J Neurosci"},{"issue":"1","key":"1926_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161(1):41\u201354","journal-title":"J Cell Biol"},{"key":"1926_CR92","doi-asserted-by":"crossref","first-page":"925050","DOI":"10.4061\/2011\/925050","volume":"2011","author":"L Pagani","year":"2011","unstructured":"Pagani L, Eckert A (2011) Amyloid-beta interaction with mitochondria. Int J Alzheimers Dis 2011:925050","journal-title":"Int J Alzheimers Dis"},{"issue":"5669","key":"1926_CR93","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1091230","volume":"304","author":"JW Lustbader","year":"2004","unstructured":"Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X et al (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease. Science. 304(5669):448\u2013452","journal-title":"Science."},{"issue":"10","key":"1926_CR94","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C et al (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat Med 14(10):1097\u20131105","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"1926_CR95","doi-asserted-by":"publisher","first-page":"S487","DOI":"10.3233\/JAD-2010-100306","volume":"20","author":"C Supnet","year":"2010","unstructured":"Supnet C, Bezprozvanny I (2010) Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer\u2019s disease. J Alzheimers Dis 20(Suppl 2):S487\u2013S498","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1926_CR96","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8(9):663\u2013672","journal-title":"Nat Rev Neurosci"},{"issue":"25","key":"1926_CR97","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1074\/jbc.M500356200","volume":"280","author":"DC David","year":"2005","unstructured":"David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, Ravid R, Dr\u00f6se S et al (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction inP301L tau transgenic mice. J Biol Chem 280(25):23802\u201323814","journal-title":"J Biol Chem"},{"issue":"8","key":"1926_CR98","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.bbadis.2013.08.013","volume":"1842","author":"A Eckert","year":"2014","unstructured":"Eckert A, Nisbet R, Grimm A, G\u00f6tz J (2014) March separate, strike together\u2014role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta 1842(8):1258\u20131266","journal-title":"Biochim Biophys Acta"},{"key":"1926_CR99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fnins.2018.00163","volume":"12","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Bai F (2018) The Association of tau with mitochondrial dysunction in Alzheimer\u2019s disease. Front Neurosci 12:163","journal-title":"Front Neurosci"},{"issue":"3","key":"1926_CR100","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1083\/jcb.143.3.777","volume":"143","author":"A Ebneth","year":"1998","unstructured":"Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer\u2019s disease. J Cell Biol 143(3):777\u2013794","journal-title":"J Cell Biol"},{"issue":"4","key":"1926_CR101","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.ajpath.2011.07.004","volume":"179","author":"KJ Kopeikina","year":"2011","unstructured":"Kopeikina KJ, Carlson GA, Pitstick R, Ludvigson AE, Peters A, Luebke JI, Koffie RM, Frosch MP et al (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer\u2019s disease brain. Am J Pathol 179(4):2071\u20132082","journal-title":"Am J Pathol"},{"issue":"11","key":"1926_CR102","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/hmg\/dds072","volume":"21","author":"M Manczak","year":"2012","unstructured":"Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21(11):2538\u20132547","journal-title":"Hum Mol Genet"},{"key":"1926_CR103","doi-asserted-by":"publisher","first-page":"24756","DOI":"10.1038\/srep24756","volume":"6","author":"XC Li","year":"2016","unstructured":"Li XC, Hu Y, Wang ZH, Luo Y, Zhang Y, Liu X, Feng Q, Wang Q et al (2016) Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins. Sci Rep 6:24756","journal-title":"Sci Rep"},{"issue":"47","key":"1926_CR104","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H et al (2009) Amylois-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci U S A 106(47):20057\u201320062","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"1926_CR105","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1073\/pnas.0903563106","volume":"106","author":"J Yao","year":"2009","unstructured":"Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 106(34):14670\u201314675","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1926_CR106","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang E (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1926_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH (2008) Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 7(1):97\u2013109","journal-title":"Lancet Neurol"},{"issue":"3","key":"1926_CR108","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mds.26966","volume":"32","author":"MP Giannoccaro","year":"2017","unstructured":"Giannoccaro MP, La Morgia C, Rizzo G, Carelli V (2017) Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease. Mov Disord 32(3):346\u2013363","journal-title":"Mov Disord"},{"key":"1926_CR109","doi-asserted-by":"crossref","unstructured":"Rango M, Bresolin N. Brain mitochondria, Aging, and Parkinson\u2019s Disease. Genes (Basel). 2018;9(5).","DOI":"10.3390\/genes9050250"},{"issue":"8649","key":"1926_CR110","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AH Schapira","year":"1989","unstructured":"Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1(8649):1269","journal-title":"Lancet."},{"issue":"6","key":"1926_CR111","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","volume":"55","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease. J Neurochem 55(6):2142\u20132145","journal-title":"J Neurochem"},{"issue":"Pt 2","key":"1926_CR112","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/brain\/115.2.333","volume":"115","author":"VM Mann","year":"1992","unstructured":"Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson\u2019s disease. Brain. 115(Pt 2):333\u2013342","journal-title":"Brain."},{"issue":"1\u20132","key":"1926_CR113","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0304-3940(94)90372-7","volume":"169","author":"B Janetzky","year":"1994","unstructured":"Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, Z\u00f6chling R, Boissl KW et al (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson\u2019s disease. Neurosci Lett 169(1\u20132):126\u2013128","journal-title":"Neurosci Lett"},{"issue":"6","key":"1926_CR114","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/ana.410360612","volume":"36","author":"VM Mann","year":"1994","unstructured":"Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AH (1994) Complex I, iron, and ferritin in Parkinson\u2019s disease substantia nigra. Ann Neurol 36(6):876\u2013881","journal-title":"Ann Neurol"},{"issue":"11","key":"1926_CR115","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1212\/WNL.43.11.2258","volume":"43","author":"F Cardellach","year":"1993","unstructured":"Cardellach F, Mart\u00ed MJ, Fern\u00e1ndez-Sol\u00e1 J, Mar\u00edn C, Hoek JB, Tolosa E, Urbano-M\u00e1rquez A (1993) Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson\u2019s disease. Neurology. 43(11):2258\u20132262","journal-title":"Neurology."},{"issue":"3","key":"1926_CR116","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ana.410300304","volume":"30","author":"JM Shoffner","year":"1991","unstructured":"Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30(3):332\u2013339","journal-title":"Ann Neurol"},{"issue":"4","key":"1926_CR117","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00702-004-0195-y","volume":"112","author":"K Winkler-Stuck","year":"2005","unstructured":"Winkler-Stuck K, Kirches E, Mawrin C, Dietzmann K, Lins H, Wallesch CW, Kunz WS, Wiedemann FR (2005) Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson\u2019s disease. J Neural Transm (Vienna) 112(4):499\u2013518","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"1926_CR118","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1212\/WNL.43.11.2262","volume":"43","author":"S DiDonato","year":"1993","unstructured":"DiDonato S, Zeviani M, Giovannini P, Savarese N, Rimoldi M, Mariotti C, Girotti F, Caraceni T (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson\u2019s disease patients. Neurology. 43(11):2262\u20132268","journal-title":"Neurology."},{"issue":"6","key":"1926_CR119","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW (1995) Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann Neurol 37(6):714\u2013722","journal-title":"Ann Neurol"},{"issue":"6","key":"1926_CR120","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.410320612","volume":"32","author":"D Krige","year":"1992","unstructured":"Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AH (1992) Platelet mitochondrial function in Parkinson\u2019s disease. The Royal Kings and Queens Parkinson disease research group. Ann Neurol 32(6):782\u2013788","journal-title":"Ann Neurol"},{"issue":"6","key":"1926_CR121","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 26(6):719\u2013723","journal-title":"Ann Neurol"},{"issue":"5","key":"1926_CR122","first-page":"1343","volume":"46","author":"MA Mart\u00edn","year":"1996","unstructured":"Mart\u00edn MA, Molina JA, Jim\u00e9nez-Jim\u00e9nez FJ, Benito-Le\u00f3n J, Ort\u00ed-Pareja M, Campos Y, Arenas J (1996) Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson\u2019s disease patients. Grupo-Centro de Trastornos del Movimento Neurology 46(5):1343\u20131346","journal-title":"Grupo-Centro de Trastornos del Movimento Neurology"},{"issue":"5","key":"1926_CR123","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/mds.10695","volume":"19","author":"M M\u00fcft\u00fcoglu","year":"2004","unstructured":"M\u00fcft\u00fcoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Og\u00fcs H, Dalkara T, Ozer N (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19(5):544\u2013548","journal-title":"Mov Disord"},{"issue":"1","key":"1926_CR124","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257619","volume":"4","author":"H Yoshino","year":"1992","unstructured":"Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y (1992) Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 4(1):27\u201334","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"4","key":"1926_CR125","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.410300409","volume":"30","author":"N Hattori","year":"1991","unstructured":"Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson\u2019s disease. Ann Neurol 30(4):563\u2013571","journal-title":"Ann Neurol"},{"issue":"3","key":"1926_CR126","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T et al (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163(3):1450\u20131455","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1926_CR127","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ana.410440207","volume":"44","author":"M Gu","year":"1998","unstructured":"Gu M, Cooper JM, Taanman JW, Schapira AH (1998) Mitochondrial DNA transmission of the mitochondrial defect in Parkinson\u2019s disease. Ann Neurol 44(2):177\u2013186","journal-title":"Ann Neurol"},{"issue":"4","key":"1926_CR128","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ana.410400417","volume":"40","author":"RH Swerdlow","year":"1996","unstructured":"Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP Jr, Davis RE et al (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40(4):663\u2013671","journal-title":"Ann Neurol"},{"issue":"3","key":"1926_CR129","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1(3):249\u2013254","journal-title":"Psychiatry Res"},{"issue":"4587","key":"1926_CR130","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine -analog synthesis. Science. 219(4587):979\u2013980","journal-title":"Science."},{"issue":"14","key":"1926_CR131","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 80(14):4546\u20134550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4656","key":"1926_CR132","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1126\/science.6610213","volume":"224","author":"RE Heikkila","year":"1984","unstructured":"Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224(4656):1451\u20131453","journal-title":"Science"},{"issue":"5","key":"1926_CR133","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2(5):325\u2013334","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1926_CR134","first-page":"19","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson\u2019s disease: an update. J Park Dis 1(1):19\u201333","journal-title":"J Park Dis"},{"issue":"3","key":"1926_CR135","doi-asserted-by":"publisher","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","volume":"2","author":"G Porras","year":"2012","unstructured":"Porras G, Li Q, Bezard E (2012) Modeling Parkinson\u2019s disease in Primates: the MPTP model. Cold Spring Harb Perspect Med 2(3):a009308","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"26","key":"1926_CR136","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36(26):2503\u20132508","journal-title":"Life Sci"},{"issue":"6","key":"1926_CR137","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron. 39(6):889\u2013909","journal-title":"Neuron."},{"issue":"7","key":"1926_CR138","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82(7):2173\u20132177","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1926_CR139","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","volume":"36","author":"S Przedborski","year":"2004","unstructured":"Przedborski S, Tieu K, Perier C, Vila M (2004) MPTP as a mitochondrial neurotoxic model of Parkinson\u2019s disease. J Bioenerg Biomembr 36(4):375\u2013379","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"1926_CR140","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0005-2728(98)00029-2","volume":"1364","author":"EM Degli","year":"1998","unstructured":"Degli EM (1998) Inhibitors of NADH-ubiquinone reductase: an overview. Biochim Biophys Acta 1364(2):222\u2013235","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1926_CR141","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0166-2236(00)01789-6","volume":"24","author":"P Jenner","year":"2001","unstructured":"Jenner P (2001) Parkinson\u2019s disease, pesticides and mitochondrial dysfunction. Trends Neurosci 24(5):245\u2013247","journal-title":"Trends Neurosci"},{"issue":"12","key":"1926_CR142","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"issue":"16","key":"1926_CR143","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT (2002) An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 22(16):7006\u20137015","journal-title":"J Neurosci"},{"issue":"3","key":"1926_CR144","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1471-4159.2003.01533.x","volume":"84","author":"GU H\u00f6glinger","year":"2003","unstructured":"H\u00f6glinger GU, F\u00e9ger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH et al (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84(3):491\u2013502","journal-title":"J Neurochem"},{"issue":"39","key":"1926_CR145","doi-asserted-by":"publisher","first-page":"15136","DOI":"10.1073\/pnas.0807581105","volume":"105","author":"WS Choi","year":"2008","unstructured":"Choi WS, Kruse SE, Palmiter RD, Xia Z (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A 105(39):15136\u201315141","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1926_CR146","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","volume":"88","author":"P Champy","year":"2004","unstructured":"Champy P, H\u00f6glinger GU, F\u00e9ger J, Gleye C, Hocquemiller R, Laurens A, Gu\u00e9rineau V, Lapr\u00e9vote O et al (2004) Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem 88(1):63\u201369","journal-title":"J Neurochem"},{"issue":"3","key":"1926_CR147","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/0006-291X(90)90497-B","volume":"170","author":"S Ikebe","year":"1990","unstructured":"Ikebe S, Tanaka M, Ohno K, Sato W, Hattori K, Kondo T, Mizuno Y, Ozawa T (1990) Increase of deleted mitochondrial DNA in the striatum in Parkinson\u2019s disease and senescence. Biochem Biophys Res Commun 170(3):1044\u20131048","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1926_CR148","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0006-291X(90)90698-M","volume":"172","author":"T Ozawa","year":"1990","unstructured":"Ozawa T, Tanaka M, Ikebe S, Ohno K, Kondo T, Mizuno Y (1990) Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem Biophys Res Commun 172(2):483\u2013489","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1926_CR149","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1111\/j.1471-4159.1990.tb04973.x","volume":"55","author":"P Lestienne","year":"1990","unstructured":"Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson\u2019s disease and complex I defect. J Neurochem 55(5):1810\u20131812","journal-title":"J Neurochem"},{"issue":"3","key":"1926_CR150","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0014-5793(92)80118-Z","volume":"299","author":"VM Mann","year":"1992","unstructured":"Mann VM, Cooper JM, Schapira AH (1992) Quantitation of a mitochondrial DNA deletion in Parkinson's disease. FEBS Lett 299(3):218\u2013222","journal-title":"FEBS Lett"},{"issue":"4","key":"1926_CR151","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mds.870050406","volume":"5","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Holt IJ, Sweeney M, Harding AE, Jenner P, Marsden CD (1990) Mitochondrial DNA analysis in Parkinson's disease. Mov Disord 5(4):294\u2013297","journal-title":"Mov Disord"},{"issue":"7","key":"1926_CR152","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","volume":"61","author":"G Gu","year":"2002","unstructured":"Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J (2002) Mitochondrial DNA deletions\/rearrangements in parkinson disease and related neurodegenerative disorders. J Neuropathol Exp Neurol 61(7):634\u2013639","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1926_CR153","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515\u2013517","journal-title":"Nat Genet"},{"key":"1926_CR154","doi-asserted-by":"publisher","first-page":"13548","DOI":"10.1038\/ncomms13548","volume":"7","author":"C D\u00f6lle","year":"2016","unstructured":"D\u00f6lle C, Fl\u00f8nes I, Nido GS, Miletic H, Osuagwu N, Kristoffersen S, Lilleng PK, Larsen JP et al (2016) Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun 7:13548","journal-title":"Nat Commun"},{"issue":"5","key":"1926_CR155","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"38","author":"Y Kraytsberg","year":"2006","unstructured":"Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38(5):518\u2013520","journal-title":"Nat Genet"},{"issue":"3","key":"1926_CR156","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P","volume":"61","author":"MD Brown","year":"1996","unstructured":"Brown MD, Shoffner JM, Kim YL, Jun AS, Graham BH, Cabell MF, Gurley DS, Wallace DC (1996) Mitochondrial DNA sequence analysis of four Alzheimer\u2019s and Parkinson\u2019s disease patients. Am J Med Genet 61(3):283\u2013289","journal-title":"Am J Med Genet"},{"issue":"2","key":"1926_CR157","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0169-328X(94)00209-W","volume":"28","author":"S Ikebe","year":"1995","unstructured":"Ikebe S, Tanaka M, Ozawa T (1995) Point mutations of mitochondrial genome in Parkinson\u2019s disease. Brain Res Mol Brain Res 28(2):281\u2013295","journal-title":"Brain Res Mol Brain Res"},{"issue":"1\u20132","key":"1926_CR158","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0022-510X(96)00247-X","volume":"144","author":"RM Kapsa","year":"1996","unstructured":"Kapsa RM, Jean-Francois MJ, Lertrit P, Weng S, Siregar N, Ojaimi J, Donnan G, Masters C et al (1996) Mitochondrial DNA polymorphism in substantia nigra. J Neurol Sci 144(1\u20132):204\u2013211","journal-title":"J Neurol Sci"},{"issue":"3","key":"1926_CR159","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s100480050029","volume":"1","author":"S K\u00f6sel","year":"1998","unstructured":"K\u00f6sel S, Grasbon-Frodl EM, Mautsch U, Egensperger R, von Eitzen U, Frishman D, Hofmann S, Gerbitz KD et al (1998) Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics. 1(3):197\u2013204","journal-title":"Neurogenetics."},{"issue":"5\u20136","key":"1926_CR160","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s007020200060","volume":"109","author":"G Richter","year":"2002","unstructured":"Richter G, Sonnenschein A, Gr\u00fcnewald T, Reichmann H, Janetzky B (2002) Novel mitochondrial DNA mutations in Parkinson\u2019s disease. J Neural Transm (Vienna) 109(5\u20136):721\u2013729","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"1926_CR161","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2004.11.093","volume":"326","author":"WD Parker Jr","year":"2005","unstructured":"Parker WD Jr, Parks JK (2005) Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochem Biophys Res Commun 326(3):667\u2013669","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1926_CR162","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s100489900085","volume":"2","author":"S K\u00f6sel","year":"2000","unstructured":"K\u00f6sel S, Grasbon-Frodl EM, Hagenah JM, Graeber MB, Vieregge P (2000) Parkinson disease: analysis of mitochondrial DNA in monozygotic twins. Neurogenetics. 2(4):227\u2013230","journal-title":"Neurogenetics."},{"issue":"5","key":"1926_CR163","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1006\/bbrc.2002.6388","volume":"290","author":"C Vives-Bauza","year":"2002","unstructured":"Vives-Bauza C, Andreu AL, Manfredi G, Beal MF, Janetzky B, Gruenewald TH, Lin MT (2002) Sequence analysis of the entire mitochondrial genome in Parkinson\u2019s disease. Biochem Biophys Res Commun 290(5):1593\u20131601","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1926_CR164","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1212\/WNL.54.3.703","volume":"54","author":"DK Simon","year":"2000","unstructured":"Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR (2000) Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson\u2019s disease. Neurology. 54(3):703\u2013709","journal-title":"Neurology."},{"key":"1926_CR165","doi-asserted-by":"crossref","unstructured":"Coxhead J, Kurzawa-Akanbi M, Hussain R, Pyle A, Chinnery P, Hudson G. Somatic mtDNA variation is an important component of Parkinson\u2019s disease. Neurobiol Aging. 2016;38:217.e1\u2013217.e6.","DOI":"10.1016\/j.neurobiolaging.2015.10.036"},{"issue":"6","key":"1926_CR166","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/ana.23568","volume":"71","author":"MT Lin","year":"2012","unstructured":"Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA et al (2012) Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol 71(6):850\u2013854","journal-title":"Ann Neurol"},{"issue":"4","key":"1926_CR167","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1086\/373937","volume":"72","author":"JM van der Walt","year":"2003","unstructured":"van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL et al (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72(4):804\u2013811","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1926_CR168","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.20417","volume":"57","author":"A Pyle","year":"2005","unstructured":"Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ et al (2005) Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57(4):564\u2013567","journal-title":"Ann Neurol"},{"issue":"6","key":"1926_CR169","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.ejhg.5201425","volume":"13","author":"D Ghezzi","year":"2005","unstructured":"Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P et al (2005) Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson\u2019s disease in Italians. Eur J Hum Genet 13(6):748\u2013752","journal-title":"Eur J Hum Genet"},{"key":"1926_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1427.001","volume":"1147","author":"E Khusnutdinova","year":"2008","unstructured":"Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC (2008) A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson\u2019s disease. Ann N Y Acad Sci 1147:1\u201320","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1926_CR171","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0531-5565(02)00266-8","volume":"38","author":"OA Ross","year":"2003","unstructured":"Ross OA, McCormack R, Maxwell LD, Duguid RA, Quinn DJ, Barnett YA, Rea IM, El-Agnaf OM et al (2003) mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson\u2019s disease in the Irish. Exp Gerontol 38(4):397\u2013405","journal-title":"Exp Gerontol"},{"issue":"22","key":"1926_CR172","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1212\/WNL.0b013e318294b434","volume":"80","author":"G Hudson","year":"2013","unstructured":"Hudson G, Nalls M, Evans JR, Breen DP, Winder-Rhodes S, Morrison KE, Morris HR, Williams-Gray CH et al (2013) Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology. 80(22):2042\u20132048","journal-title":"Neurology."},{"issue":"6","key":"1926_CR173","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ana.24515","volume":"78","author":"A Pyle","year":"2015","unstructured":"Pyle A, Brennan R, Kurzawa-Akanbi M, Yarnall A, Thouin A, Mollenhauer B, Burn D, Chinnery PF et al (2015) Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease. Ann Neurol 78(6):1000\u20131004","journal-title":"Ann Neurol"},{"issue":"3","key":"1926_CR174","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ana.24571","volume":"79","author":"A Gr\u00fcnewald","year":"2016","unstructured":"Gr\u00fcnewald A, Rygiel KA, Hepplewhite PD, Morris CM, Picard M, Turnbull DM (2016) Mitochondrial DNA depletion in respiratory chain-deficient Parkinson disease neurons. Ann Neurol 79(3):366\u2013378","journal-title":"Ann Neurol"},{"key":"1926_CR175","doi-asserted-by":"publisher","first-page":"216.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","volume":"38","author":"A Pyle","year":"2016","unstructured":"Pyle A, Anugrha H, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G (2016) Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease. Neurobiol Aging 38:216.e7\u2013216.e10","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1926_CR176","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/90034","volume":"28","author":"G Van Goethem","year":"2001","unstructured":"Van Goethem G, Dermaut B, L\u00f6fgren A, Martin JJ, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28(3):211\u2013212","journal-title":"Nat Genet"},{"issue":"9437","key":"1926_CR177","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(04)16983-3","volume":"364","author":"P Luoma","year":"2004","unstructured":"Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I et al (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet. 364(9437):875\u2013882","journal-title":"Lancet."},{"issue":"11","key":"1926_CR178","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/archneur.61.11.1777","volume":"61","author":"M Mancuso","year":"2004","unstructured":"Mancuso M, Filosto M, Oh SJ, DiMauro S (2004) A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and parkinsonism. Arch Neurol 61(11):1777\u20131779","journal-title":"Arch Neurol"},{"issue":"4","key":"1926_CR179","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archneur.64.4.553","volume":"64","author":"G Hudson","year":"2007","unstructured":"Hudson G, Schaefer AM, Taylor RW, Tiangyou W, Gibson A, Venables G, Griffiths P, Burn DJ et al (2007) Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and parkinsonism. Arch Neurol 64(4):553\u2013557","journal-title":"Arch Neurol"},{"issue":"6","key":"1926_CR180","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.nmd.2008.04.005","volume":"18","author":"F Invernizzi","year":"2008","unstructured":"Invernizzi F, Varanese S, Thomas A, Carrara F, Onofrj M, Zeviani M (2008) Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. Neuromuscul Disord 18(6):460\u2013464","journal-title":"Neuromuscul Disord"},{"key":"1926_CR181","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2377-13-92","volume":"13","author":"R Dolhun","year":"2013","unstructured":"Dolhun R, Presant EM, Hedera P (2013) Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism. BMC Neurol 13:92","journal-title":"BMC Neurol"},{"key":"1926_CR182","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clineuro.2014.08.020","volume":"126","author":"R Miguel","year":"2014","unstructured":"Miguel R, Gago MF, Martins J, Barros P, Vale J, Rosas MJ (2014) POLG1-related levodopa-responsive parkinsonism. Clin Neurol Neurosurg 126:47\u201354","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"1926_CR183","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.parkreldis.2008.01.009","volume":"14","author":"AM Remes","year":"2008","unstructured":"Remes AM, Hinttala R, K\u00e4rpp\u00e4 M, Soini H, Takalo R, Uusimaa J, Majamaa K (2008) Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism Relat Disord 14(8):652\u2013654","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1926_CR184","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/mds.22865","volume":"25","author":"M Synofzik","year":"2010","unstructured":"Synofzik M, Asmus F, Reimold M, Sch\u00f6ls L, Berg D (2010) Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism. Mov Disord 25(2):243\u2013245","journal-title":"Mov Disord"},{"issue":"5","key":"1926_CR185","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ana.20831","volume":"59","author":"G Davidzon","year":"2006","unstructured":"Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S (2006) Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59(5):859\u2013862","journal-title":"Ann Neurol"},{"issue":"1","key":"1926_CR186","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2990.2008.00981.x","volume":"35","author":"J Betts-Henderson","year":"2009","unstructured":"Betts-Henderson J, Jaros E, Krishnan KJ, Perry RH, Reeve AK, Schaefer AM, Taylor RW, Turnbull DM (2009) Alpha-synuclein pathology and parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol 35(1):120\u2013124","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"1926_CR187","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00401-005-1047-z","volume":"110","author":"A Melberg","year":"2005","unstructured":"Melberg A, Nennesmo I, Moslemi AR, Kollberg G, Luoma P, Suomalainen A, Holme E, Oldfors A (2005) Alzheimer pathology associated with POLG1 mutation, multiple mtDNA deletions, and APOE4\/4: premature ageing or just coincidence? Acta Neuropathol 110(3):315\u2013316","journal-title":"Acta Neuropathol"},{"issue":"Pt 8","key":"1926_CR188","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1093\/brain\/awt103","volume":"136","author":"C Tzoulis","year":"2013","unstructured":"Tzoulis C, Tran GT, Schwarzlm\u00fcller T, Specht K, Haugarvoll K, Balafkan N, Lilleng PK, Miletic H et al (2013) Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain. 136(Pt 8):2393\u20132404","journal-title":"Brain."},{"issue":"12","key":"1926_CR189","doi-asserted-by":"publisher","first-page":"e50086","DOI":"10.1371\/journal.pone.0050086","volume":"7","author":"YX Gui","year":"2012","unstructured":"Gui YX, Xu ZP, Lv W, Liu HM, Zhao JJ, Hu XY (2012) Association of mitochondrial DNA polymerase \u03b3 gene POLG1 polymorphisms with parkinsonism in Chinese populations. PLoS One 7(12):e50086","journal-title":"PLoS One"},{"issue":"7","key":"1926_CR190","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/mds.22310","volume":"24","author":"G Hudson","year":"2009","unstructured":"Hudson G, Tiangyou W, Stutt A, Eccles M, Robinson L, Burn DJ, Chinnery PF (2009) No association between common POLG1 variants and sporadic idiopathic Parkinson\u2019s disease. Mov Disord 24(7):1092\u20131094","journal-title":"Mov Disord"},{"issue":"11","key":"1926_CR191","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1212\/01.wnl.0000276955.23735.eb","volume":"69","author":"PT Luoma","year":"2007","unstructured":"Luoma PT, Eerola J, Ahola S, Hakonen AH, Hellstr\u00f6m O, Kivist\u00f6 KT, Tienari PJ, Suomalainen A (2007) Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology. 69(11):1152\u20131159","journal-title":"Neurology."},{"issue":"9","key":"1926_CR192","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/01.wnl.0000238963.07425.d5","volume":"67","author":"W Tiangyou","year":"2006","unstructured":"Tiangyou W, Hudson G, Ghezzi D, Ferrari G, Zeviani M, Burn DJ, Chinnery PF (2006) POLG1 in idiopathic Parkinson disease. Neurology. 67(9):1698\u20131700","journal-title":"Neurology."},{"issue":"12","key":"1926_CR193","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00415-013-7132-7","volume":"260","author":"S Yl\u00f6nen","year":"2013","unstructured":"Yl\u00f6nen S, Ylikotila P, Siitonen A, Finnil\u00e4 S, Autere J, Majamaa K (2013) Variations of mitochondrial DNA polymerase \u03b3 in patients with Parkinson\u2019s disease. J Neurol 260(12):3144\u20133149","journal-title":"J Neurol"},{"issue":"2","key":"1926_CR194","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neulet.2010.08.082","volume":"485","author":"A Anvret","year":"2010","unstructured":"Anvret A, Westerlund M, Sydow O, Willows T, Lind C, Galter D, Belin AC (2010) Variations of the CAG trinucleotide repeat in DNA polymerase \u03b3 (POLG1) is associated with Parkinson\u2019s disease in Sweden. Neurosci Lett 485(2):117\u2013120","journal-title":"Neurosci Lett"},{"issue":"6","key":"1926_CR195","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.mito.2012.08.004","volume":"12","author":"N Balafkan","year":"2012","unstructured":"Balafkan N, Tzoulis C, M\u00fcller B, Haugarvoll K, Tysnes OB, Larsen JP, Bindoff LA (2012) Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion. 12(6):640\u2013643","journal-title":"Mitochondrion."},{"issue":"1","key":"1926_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2010.04.021","volume":"477","author":"J Eerola","year":"2010","unstructured":"Eerola J, Luoma PT, Peuralinna T, Scholz S, Paisan-Ruiz C, Suomalainen A, Singleton AB, Tienari PJ (2010) POLG1 polyglutamine tract variants associated with Parkinson\u2019s disease. Neurosci Lett 477(1):1\u20135","journal-title":"Neurosci Lett"},{"key":"1926_CR197","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mito.2014.01.004","volume":"15","author":"SR Bentley","year":"2014","unstructured":"Bentley SR, Shan J, Todorovic M, Wood SA, Mellick GD (2014) Rare POLG1 CAG variants do not influence Parkinson's disease or polymerase gamma function. Mitochondrion. 15:65\u201368","journal-title":"Mitochondrion."},{"issue":"1","key":"1926_CR198","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2004.11.023","volume":"376","author":"JW Taanman","year":"2005","unstructured":"Taanman JW, Schapira AH (2005) Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson\u2019s disease. Neurosci Lett 376(1):56\u201359","journal-title":"Neurosci Lett"},{"issue":"7","key":"1926_CR199","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/archneur.64.7.998","volume":"64","author":"RH Baloh","year":"2007","unstructured":"Baloh RH, Salavaggione E, Milbrandt J, Pestronk A (2007) Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch Neurol 64(7):998\u20131000","journal-title":"Arch Neurol"},{"key":"1926_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2013.09.034","volume":"556","author":"L Kiferle","year":"2013","unstructured":"Kiferle L, Orsucci D, Mancuso M, Lo Gerfo A, Petrozzi L, Siciliano G, Ceravolo R, Bonuccelli U (2013) Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: a case report and an update on the state of art. Neurosci Lett 556:1\u20134","journal-title":"Neurosci Lett"},{"issue":"2","key":"1926_CR201","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/mds.22198","volume":"24","author":"W Vandenberghe","year":"2009","unstructured":"Vandenberghe W, Van Laere K, Debruyne F, Van Broeckhoven C, Van Goethem G (2009) Neurodegenerative parkinsonism and progressive external ophthalmoplegia with a twinkle mutation. Mov Disord 24(2):308\u2013309","journal-title":"Mov Disord"},{"issue":"3","key":"1926_CR202","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/90058","volume":"28","author":"JN Spelbrink","year":"2001","unstructured":"Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28(3):223\u2013231","journal-title":"Nat Genet"},{"issue":"6676","key":"1926_CR203","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 392(6676):605\u2013608","journal-title":"Nature."},{"issue":"5674","key":"1926_CR204","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D et al (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science. 304(5674):1158\u20131160","journal-title":"Science."},{"issue":"10","key":"1926_CR205","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tcb.2016.05.008","volume":"26","author":"TN Nguyen","year":"2016","unstructured":"Nguyen TN, Padman BS, Lazarou M (2016) Deciphering the molecular signals of PINK1\/Parkin mitophagy. Trends Cell Biol 26(10):733\u2013744","journal-title":"Trends Cell Biol"},{"issue":"7097","key":"1926_CR206","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA et al (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 441(7097):1162\u20131166","journal-title":"Nature."},{"issue":"7097","key":"1926_CR207","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 441(7097):1157\u20131161","journal-title":"Nature."},{"issue":"Pt A","key":"1926_CR208","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mcn.2015.02.008","volume":"66","author":"RA Charan","year":"2015","unstructured":"Charan RA, LaVoie MJ (2015) Pathologic and therapeutic implications for the cell biology of parkin. Mol Cell Neurosci 66(Pt A):62\u201371","journal-title":"Mol Cell Neurosci"},{"issue":"19","key":"1926_CR209","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1073\/pnas.0711845105","volume":"105","author":"Y Yang","year":"2008","unstructured":"Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission\/fusion machinery. Proc Natl Acad Sci U S A 105(19):7070\u20137075","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"1926_CR210","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1073\/pnas.0803998105","volume":"105","author":"H Deng","year":"2008","unstructured":"Deng H, Dodson MW, Huang H, Guo M (2008) The Parkinson\u2019s disease genes pink1 and parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A 105(38):14503\u201314508","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1926_CR211","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","volume":"97","author":"DG Ordonez","year":"2018","unstructured":"Ordonez DG, Lee MK, Feany MB (2018) \u03b1-synuclein induces mitochondrial dysfunction through spectrin and the actin cytoskeleton. Neuron 97(1):108\u2013124.e6","journal-title":"Neuron"},{"issue":"34","key":"1926_CR212","doi-asserted-by":"publisher","first-page":"22938","DOI":"10.1074\/jbc.M109.035774","volume":"284","author":"AK Lutz","year":"2009","unstructured":"Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, L\u00e4mmermann K, Brunner B, Kurz-Drexler A et al (2009) Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 284(34):22938\u201322951","journal-title":"J Biol Chem"},{"key":"1926_CR213","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1038\/ncomms6244","volume":"5","author":"PM Rappold","year":"2014","unstructured":"Rappold PM, Cui M, Grima JC, Fan RZ, de Mesy-Bentley KL, Chen L, Zhuang X, Bowers WJ et al (2014) Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nat Commun 5:5244","journal-title":"Nat Commun"},{"issue":"18","key":"1926_CR214","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279(18):18614\u201318622","journal-title":"J Biol Chem"},{"issue":"7","key":"1926_CR215","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A 100(7):4078\u20134083","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"141","key":"1926_CR216","doi-asserted-by":"publisher","first-page":"141ra90","DOI":"10.1126\/scitranslmed.3003985","volume":"4","author":"O Cooper","year":"2012","unstructured":"Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L et al (2012) Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson\u2019s disease. Sci Transl Med 4(141):141ra90","journal-title":"Sci Transl Med"},{"key":"1926_CR217","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-5-35","volume":"5","author":"Y Imaizumi","year":"2012","unstructured":"Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T et al (2012) Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:35","journal-title":"Mol Brain"},{"key":"1926_CR218","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ncomms1669","volume":"3","author":"H Jiang","year":"2012","unstructured":"Jiang H, Ren Y, Yuen EY, Zhong P, Ghaedi M, Hu Z, Azabdaftari G, Nakaso K et al (2012) Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun 3:668","journal-title":"Nat Commun"},{"issue":"16","key":"1926_CR219","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","volume":"31","author":"P Seibler","year":"2011","unstructured":"Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D (2011) Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci 31(16):5970\u20135976","journal-title":"J Neurosci"},{"issue":"5","key":"1926_CR220","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","volume":"4","author":"A Shaltouki","year":"2015","unstructured":"Shaltouki A, Sivapatham R, Pei Y, Gerencser AA, Mom\u010dilovi\u0107 O, Rao MS, Zeng X (2015) Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Reports 4(5):847\u2013859","journal-title":"Stem Cell Reports"},{"issue":"1","key":"1926_CR221","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbrc.2016.12.188","volume":"483","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, Akamatsu W, Kisa F, Sone T, Ishikawa KI, Kuzumaki N, Katayama H, Miyawaki A et al (2017) Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem Biophys Res Commun 483(1):88\u201393","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1926_CR222","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","volume":"11","author":"Y Tabata","year":"2018","unstructured":"Tabata Y, Imaizumi Y, Sugawara M, Andoh-Noda T, Banno S, Chai M, Sone T, Yamazaki K et al (2018) T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease. Stem Cell Reports 11(5):1171\u20131184","journal-title":"Stem Cell Reports"},{"issue":"45","key":"1926_CR223","doi-asserted-by":"publisher","first-page":"12413","DOI":"10.1523\/JNEUROSCI.0719-07.2007","volume":"27","author":"N Exner","year":"2007","unstructured":"Exner N, Treske B, Paquet D, Holmstr\u00f6m K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D et al (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27(45):12413\u201312418","journal-title":"J Neurosci"},{"issue":"6645","key":"1926_CR224","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature. 388(6645):839\u2013840","journal-title":"Nature."},{"issue":"6","key":"1926_CR225","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron. 79(6):1044\u20131066","journal-title":"Neuron."},{"issue":"1","key":"1926_CR226","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14(1):38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"1926_CR227","doi-asserted-by":"crossref","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302(5646):841.","DOI":"10.1126\/science.1090278"},{"issue":"5321","key":"1926_CR228","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science. 276(5321):2045\u20132047","journal-title":"Science."},{"issue":"2","key":"1926_CR229","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108","journal-title":"Nat Genet"},{"issue":"2","key":"1926_CR230","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173","journal-title":"Ann Neurol"},{"key":"1926_CR231","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","volume":"70","author":"SR Subramaniam","year":"2014","unstructured":"Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF (2014) Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiol Dis 70:204\u2013213","journal-title":"Neurobiol Dis"},{"issue":"12","key":"1926_CR232","doi-asserted-by":"publisher","first-page":"e85815","DOI":"10.1371\/journal.pone.0085815","volume":"8","author":"L Li","year":"2013","unstructured":"Li L, Nadanaciva S, Berger Z, Shen W, Paumier K, Schwartz J, Mou K, Loos P et al (2013) Human A53T \u03b1-synuclein causes reversible deficits in mitochondrial function and dynamics in primary mouse cortical neurons. PLoS One 8(12):e85815","journal-title":"PLoS One"},{"issue":"31","key":"1926_CR233","doi-asserted-by":"publisher","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","volume":"289","author":"ES Luth","year":"2014","unstructured":"Luth ES, Stavrovskaya IG, Bartels T, Kristal BS, Selkoe DJ (2014) Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289(31):21490\u201321507","journal-title":"J Biol Chem"},{"issue":"8","key":"1926_CR234","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","volume":"584","author":"K Banerjee","year":"2010","unstructured":"Banerjee K, Sinha M, Pham Cle L, Jana S, Chanda D, Cappai R, Chakrabarti S (2010) Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson\u2019s disease. FEBS Lett 584(8):1571\u20131576","journal-title":"FEBS Lett"},{"issue":"7\u20138","key":"1926_CR235","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","volume":"65","author":"MS Parihar","year":"2008","unstructured":"Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P (2008) Mitochondrial association of alpha-synuclein causes oxidative stress. Cell Mol Life Sci 65(7\u20138):1272\u20131284","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"1926_CR236","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"V Tapias","year":"2017","unstructured":"Tapias V, Hu X, Luk KC, Sanders LH, Lee VM, Greenamyre JT (2017) Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol Life Sci 74(15):2851\u20132874","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1926_CR237","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta SJ, Mallajosyula JK, Rane A, Andersen JK (2010) Mitochondrial \u03b1-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486(3):235\u2013239","journal-title":"Neurosci Lett"},{"issue":"10","key":"1926_CR238","doi-asserted-by":"publisher","first-page":"7334","DOI":"10.1074\/jbc.M109.061051","volume":"285","author":"V Loeb","year":"2010","unstructured":"Loeb V, Yakunin E, Saada A, Sharon R (2010) The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J Biol Chem 285(10):7334\u20137343","journal-title":"J Biol Chem"},{"issue":"14","key":"1926_CR239","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283(14):9089\u20139100","journal-title":"J Biol Chem"},{"key":"1926_CR240","doi-asserted-by":"publisher","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"AK Reeve","year":"2015","unstructured":"Reeve AK, Ludtmann MH, Angelova PR, Simcox EM, Horrocks MH, Klenerman D, Gandhi S, Turnbull DM et al (2015) Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6:e1820","journal-title":"Cell Death Dis"},{"issue":"3","key":"1926_CR241","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","volume":"454","author":"G Liu","year":"2009","unstructured":"Liu G, Zhang C, Yin J, Li X, Cheng F, Li Y, Yang H, U\u00e9da K et al (2009) alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 454(3):187\u2013192","journal-title":"Neurosci Lett"},{"issue":"2","key":"1926_CR242","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","volume":"186","author":"DD Song","year":"2004","unstructured":"Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186(2):158\u2013172","journal-title":"Exp Neurol"},{"issue":"6","key":"1926_CR243","doi-asserted-by":"publisher","first-page":"e0131281","DOI":"10.1371\/journal.pone.0131281","volume":"10","author":"LK Song","year":"2015","unstructured":"Song LK, Ma KL, Yuan YH, Mu Z, Song XY, Niu F, Han N, Chen NH (2015) Targeted overexpression of \u03b1-Synuclein by rAAV2\/1 vectors induces progressive nigrostriatal degeneration and increases vulnerability to MPTP in mouse. PLoS One 10(6):e0131281","journal-title":"PLoS One"},{"issue":"6","key":"1926_CR244","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neurobiolaging.2005.04.010","volume":"27","author":"M Nieto","year":"2006","unstructured":"Nieto M, Gil-Bea FJ, Dalf\u00f3 E, Cuadrado M, Cabodevilla F, S\u00e1nchez B, Catena S, Sesma T et al (2006) Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 27(6):848\u2013856","journal-title":"Neurobiol Aging"},{"issue":"22","key":"1926_CR245","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K et al (2002) Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci U S A 99(22):14524\u201314529","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1926_CR246","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.nbd.2005.08.018","volume":"21","author":"P Klivenyi","year":"2006","unstructured":"Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW et al (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 21(3):541\u2013548","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1926_CR247","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jnr.21125","volume":"85","author":"TM Fountaine","year":"2007","unstructured":"Fountaine TM, Wade-Martins R (2007) RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J Neurosci Res 85(2):351\u2013363","journal-title":"J Neurosci Res"},{"key":"1926_CR248","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","volume":"240","author":"JR Cannon","year":"2013","unstructured":"Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK, Li C, Greenamyre JT (2013) Expression of human E46K-mutated \u03b1-synuclein in BAC-transgenic rats replicates early-stage Parkinson\u2019s disease features and enhances vulnerability to mitochondrial impairment. Exp Neurol 240:44\u201356","journal-title":"Exp Neurol"},{"issue":"2","key":"1926_CR249","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neulet.2008.05.005","volume":"439","author":"S Shavali","year":"2008","unstructured":"Shavali S, Brown-Borg HM, Ebadi M, Porter J (2008) Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells. Neurosci Lett 439(2):125\u2013128","journal-title":"Neurosci Lett"},{"issue":"7","key":"1926_CR250","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1172\/JCI64502","volume":"125","author":"AD Zharikov","year":"2015","unstructured":"Zharikov AD, Cannon JR, Tapias V, Bai Q, Horowitz MP, Shah V, El Ayadi A, Hastings TG et al (2015) shRNA targeting \u03b1-synuclein prevents neurodegeneration in a Parkinson's disease model. J Clin Invest 125(7):2721\u20132735","journal-title":"J Clin Invest"},{"issue":"9","key":"1926_CR251","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL et al (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci U S A 102(9):3413\u20133418","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"1926_CR252","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.1523\/JNEUROSCI.1659-16.2016","volume":"36","author":"MH Ludtmann","year":"2016","unstructured":"Ludtmann MH, Angelova PR, Ninkina NN, Gandhi S, Buchman VL, Abramov AY (2016) Monomeric alpha-synuclein exerts a physiological role on brain ATP synthase. J Neurosci 36(41):10510\u201310521","journal-title":"J Neurosci"},{"issue":"342","key":"1926_CR253","doi-asserted-by":"publisher","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J et al (2016) \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8(342):342ra78","journal-title":"Sci Transl Med"},{"issue":"4","key":"1926_CR254","doi-asserted-by":"publisher","first-page":"e62277","DOI":"10.1371\/journal.pone.0062277","volume":"8","author":"A Bender","year":"2013","unstructured":"Bender A, Desplats P, Spencer B, Rockenstein E, Adame A, Elstner M, Laub C, Mueller S et al (2013) TOM40 mediates mitochondrial dysfunction induced by \u03b1-synuclein accumulation in Parkinson\u2019s disease. PLoS One 8(4):e62277","journal-title":"PLoS One"},{"issue":"20","key":"1926_CR255","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","volume":"29","author":"F Kamp","year":"2010","unstructured":"Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T et al (2010) Inhibition of mitochondrial fusion by \u03b1-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29(20):3571\u20133589","journal-title":"EMBO J"},{"issue":"23","key":"1926_CR256","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","volume":"286","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J et al (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 286(23):20710\u201320726","journal-title":"J Biol Chem"},{"issue":"1","key":"1926_CR257","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","volume":"34","author":"C Guardia-Laguarta","year":"2014","unstructured":"Guardia-Laguarta C, Area-Gomez E, R\u00fcb C, Liu Y, Magran\u00e9 J, Becker D, Voos W, Schon EA et al (2014) \u03b1-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 34(1):249\u2013259","journal-title":"J Neurosci"},{"issue":"8","key":"1926_CR258","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/mds.26239","volume":"30","author":"C Guardia-Laguarta","year":"2015","unstructured":"Guardia-Laguarta C, Area-Gomez E, Schon EA, Przedborski S (2015) A new role for \u03b1-synuclein in Parkinson\u2019s disease: alteration of ER-mitochondrial communication. Mov Disord 30(8):1026\u20131033","journal-title":"Mov Disord"},{"issue":"11","key":"1926_CR259","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","volume":"34","author":"K Ubhi","year":"2011","unstructured":"Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 34(11):581\u2013590","journal-title":"Trends Neurosci"},{"issue":"1","key":"1926_CR260","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40478-019-0730-6","volume":"7","author":"G Monzio Compagnoni","year":"2019","unstructured":"Monzio Compagnoni G, Di Fonzo A (2019) Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives. Acta Neuropathol Commun 7(1):113","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1926_CR261","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0022-510X(94)90248-8","volume":"125","author":"O Blin","year":"1994","unstructured":"Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP, Bill\u00e9 F, Figarella D et al (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 125(1):95\u2013101","journal-title":"J Neurol Sci"},{"issue":"3","key":"1926_CR262","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/mds.870120323","volume":"12","author":"M Gu","year":"1997","unstructured":"Gu M, Gash MT, Cooper JM, Wenning GK, Daniel SE, Quinn NP, Marsden CD, Schapira AH (1997) Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 12(3):418\u2013422","journal-title":"Mov Disord"},{"issue":"3","key":"1926_CR263","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"Multiple-System Atrophy Research Collaboration","year":"2013","unstructured":"Multiple-System Atrophy Research Collaboration (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med 369(3):233\u2013244","journal-title":"N Engl J Med"},{"issue":"5","key":"1926_CR264","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/biof.155","volume":"37","author":"CM Quinzii","year":"2011","unstructured":"Quinzii CM, Hirano M (2011) Primary and secondary CoQ(10) deficiencies in humans. Biofactors. 37(5):361\u2013365","journal-title":"Biofactors."},{"issue":"2","key":"1926_CR265","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/500092","volume":"78","author":"C Quinzii","year":"2006","unstructured":"Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M (2006) A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78(2):345\u2013349","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1926_CR266","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.26138","volume":"30","author":"CH Lin","year":"2015","unstructured":"Lin CH, Tan EK, Yang CC, Yi Z, Wu RM (2015) COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in Chinese. Mov Disord 30(3):436\u2013437","journal-title":"Mov Disord"},{"key":"1926_CR267","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-9-44","volume":"9","author":"K Ogaki","year":"2014","unstructured":"Ogaki K, Fujioka S, Heckman MG, Rayaprolu S, Soto-Ortolaza AI, Labb\u00e9 C, Walton RL, Lorenzo-Betancor O et al (2014) Analysis of COQ2 gene in multiple system atrophy. Mol Neurodegener 9:44","journal-title":"Mol Neurodegener"},{"key":"1926_CR268","doi-asserted-by":"crossref","unstructured":"Ronchi D, Di Biase E, Franco G, Melzi V, Del Sorbo F, Elia A, Barzaghi C, Garavaglia B, Bergamini C, Fato R, Mora G, Del Bo R, Fortunato F, Borellini L, Trezzi I, Compagnoni GM, Monfrini E, Frattini E, Bonato S, Cogiamanian F, Ardolino G, Priori A, Bresolin N, Corti S, Comi GP, Di Fonzo A. Mutational analysis of COQ2 in patients with MSA in Italy. Neurobiol Aging. 2016;45:213.e1\u2013213.e2.","DOI":"10.1016\/j.neurobiolaging.2016.05.022"},{"issue":"1","key":"1926_CR269","first-page":"81","volume":"371","author":"LV Schottlaender","year":"2014","unstructured":"Schottlaender LV, Houlden H (2014) Multiple-System Atrophy (MSA) Brain bank collaboration. Mutant COQ2 in multiple-system atrophy. N Engl J Med 371(1):81","journal-title":"N Engl J Med"},{"key":"1926_CR270","doi-asserted-by":"crossref","unstructured":"Sharma M, Wenning G, Kr\u00fcger R; European multiple-system atrophy study group (EMSA-SG). Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371(1):80\u201381.","DOI":"10.1056\/NEJMc1311763"},{"issue":"3","key":"1926_CR271","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10072-015-2414-8","volume":"37","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Yang X, Tian S, An R, Zheng J, Xu Y (2016) Association of the COQ2 V393A variant with risk of multiple system atrophy in East Asians: a case-control study and meta-analysis of the literature. Neurol Sci 37(3):423\u2013430","journal-title":"Neurol Sci"},{"issue":"7","key":"1926_CR272","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jnen\/nlw037","volume":"75","author":"E Barca","year":"2016","unstructured":"Barca E, Kleiner G, Tang G, Ziosi M, Tadesse S, Masliah E, Louis ED, Faust P et al (2016) Decreased coenzyme Q10 levels in multiple system atrophy cerebellum. J Neuropathol Exp Neurol 75(7):663\u2013672","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1926_CR273","doi-asserted-by":"publisher","first-page":"e0149557","DOI":"10.1371\/journal.pone.0149557","volume":"11","author":"LV Schottlaender","year":"2016","unstructured":"Schottlaender LV, Bettencourt C, Kiely AP, Chalasani A, Neergheen V, Holton JL, Hargreaves I, Houlden H (2016) Coenzyme Q10 levels are decreased in the cerebellum of multiple-system atrophy patients. PLoS One 11(2):e0149557","journal-title":"PLoS One"},{"key":"1926_CR274","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2017.10.010","volume":"46","author":"Y Compta","year":"2018","unstructured":"Compta Y, Giraldo DM, Mu\u00f1oz E, Antonelli F, Fern\u00e1ndez M, Bravo P, Soto M, C\u00e1mara A et al (2018) Catalan MSA Registry (CMSAR). Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy. Parkinsonism Relat Disord 46:16\u201323","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"1926_CR275","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaneurol.2016.1325","volume":"73","author":"J Mitsui","year":"2016","unstructured":"Mitsui J, Matsukawa T, Yasuda T, Ishiura H, Tsuji S (2016) Plasma coenzyme Q10 levels in patients with multiple system atrophy. JAMA Neurol 73(8):977\u2013980","journal-title":"JAMA Neurol"},{"issue":"1","key":"1926_CR276","doi-asserted-by":"publisher","first-page":"e0147574","DOI":"10.1371\/journal.pone.0147574","volume":"11","author":"T Kasai","year":"2016","unstructured":"Kasai T, Tokuda T, Ohmichi T, Ishii R, Tatebe H, Nakagawa M, Mizuno T (2016) Serum levels of coenzyme Q10 in patients with multiple system atrophy. PLoS One 11(1):e0147574","journal-title":"PLoS One"},{"issue":"12","key":"1926_CR277","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","volume":"1864","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Bordoni A, Fortunato F, Ronchi D, Salani S, Guida M, Corti C et al (2018) Mitochondrial dysfunction in fibroblasts of multiple system atrophy. Biochim Biophys Acta Mol basis Dis 1864(12):3588\u20133597","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"5","key":"1926_CR278","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","volume":"11","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Samarani M, Aureli M, Faustini G, Bellucci A, Ronchi D, Bordoni A et al (2018) Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy. Stem Cell Reports 11(5):1185\u20131198","journal-title":"Stem Cell Reports"},{"issue":"1","key":"1926_CR279","doi-asserted-by":"publisher","first-page":"14215","DOI":"10.1038\/s41598-018-32573-1","volume":"8","author":"FK Nakamoto","year":"2018","unstructured":"Nakamoto FK, Okamoto S, Mitsui J, Sone T, Ishikawa M, Yamamoto Y, Kanegae Y, Nakatake Y et al (2018) The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy. Sci Rep 8(1):14215","journal-title":"Sci Rep"},{"issue":"3","key":"1926_CR280","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 166(3):869\u2013876","journal-title":"Am J Pathol"},{"issue":"12","key":"1926_CR281","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/jnr.22089","volume":"87","author":"K Ubhi","year":"2009","unstructured":"Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK et al (2009) Mitochondrial inhibitor 3-nitropropionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res 87(12):2728\u20132739","journal-title":"J Neurosci Res"},{"issue":"6","key":"1926_CR282","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12(6):359\u2013366","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1926_CR283","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2005.01.027","volume":"120","author":"TB Kirkwood","year":"2005","unstructured":"Kirkwood TB (2005) Understanding the odd science of aging. Cell. 120(4):437\u2013447","journal-title":"Cell."},{"issue":"9","key":"1926_CR284","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1172\/JCI120842","volume":"128","author":"JY Jang","year":"2018","unstructured":"Jang JY, Blum A, Liu J, Finkel T (2018) The role of mitochondria in aging. J Clin Invest 128(9):3662\u20133670","journal-title":"J Clin Invest"},{"issue":"5","key":"1926_CR285","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun N, Youle RJ, Finkel T (2016) The mitochondrial basis of aging. Mol Cell 61(5):654\u2013666","journal-title":"Mol Cell"},{"key":"1926_CR286","doi-asserted-by":"crossref","unstructured":"Theurey P, Pizzo P. The Aging Mitochondria. Genes (Basel). 2018;9(1).","DOI":"10.3390\/genes9010022"},{"issue":"4","key":"1926_CR287","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ng1292-324","volume":"2","author":"M Corral-Debrinski","year":"1992","unstructured":"Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2(4):324\u2013329","journal-title":"Nat Genet"},{"issue":"1\u20132","key":"1926_CR288","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0027-5107(03)00010-1","volume":"526","author":"M Khaidakov","year":"2003","unstructured":"Khaidakov M, Heflich RH, Manjanatha MG, Myers MB, Aidoo A (2003) Accumulation of point mutations in mitochondrial DNA of aging mice. Mutat Res 526(1\u20132):1\u20137","journal-title":"Mutat Res"},{"issue":"2","key":"1926_CR289","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0047-6374(95)01611-3","volume":"83","author":"SR Schwarze","year":"1995","unstructured":"Schwarze SR, Lee CM, Chung SS, Roecker EB, Weindruch R, Aiken JM (1995) High levels of mitochondrial DNA deletions in skeletal muscle of old rhesus monkeys. Mech Ageing Dev 83(2):91\u2013101","journal-title":"Mech Ageing Dev"},{"key":"1926_CR290","doi-asserted-by":"crossref","unstructured":"Ojaimi J, Masters CL, Opeskin K, McKelvie P, Byrne E. Mitochondrial respiratory chain activity in the human brain as a function of age. Mech Ageing Dev 1999;111(1):39\u201347.","DOI":"10.1016\/S0047-6374(99)00071-8"},{"issue":"6","key":"1926_CR291","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.mad.2008.02.010","volume":"129","author":"CC Preston","year":"2008","unstructured":"Preston CC, Oberlin AS, Holmuhamedov EL, Gupta A, Sagar S, Syed RH, Siddiqui SA, Raghavakaimal S et al (2008) Aging-induced alterations in gene transcripts and functional activity of mitochondrial oxidative phosphorylation complexes in the heart. Mech Ageing Dev 129(6):304\u2013312","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"1926_CR292","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2015.10.009","volume":"60","author":"N Sun","year":"2015","unstructured":"Sun N, Yun J, Liu J, Malide D, Liu C, Rovira II, Holmstr\u00f6m KM, Fergusson MM et al (2015) Measuring in vivo mitophagy. Mol Cell 60(4):685\u2013696","journal-title":"Mol Cell"},{"issue":"3","key":"1926_CR293","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","volume":"11","author":"D Harman","year":"1956","unstructured":"Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11(3):298\u2013300","journal-title":"J Gerontol"},{"issue":"6990","key":"1926_CR294","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature02517","volume":"429","author":"A Trifunovic","year":"2004","unstructured":"Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidl\u00f6f S et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 429(6990):417\u2013423","journal-title":"Nature."},{"issue":"5733","key":"1926_CR295","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.1112125","volume":"309","author":"GC Kujoth","year":"2005","unstructured":"Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY et al (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 309(5733):481\u2013484","journal-title":"Science."},{"issue":"1\u20132","key":"1926_CR296","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbabio.2004.03.014","volume":"1658","author":"S DiMauro","year":"2004","unstructured":"DiMauro S (2004) Mitochondrial diseases. Biochim Biophys Acta 1658(1\u20132):80\u201388","journal-title":"Biochim Biophys Acta"},{"key":"1926_CR297","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli C, Giguere N, Bourque M, Levesque M, Ruth SS, Trudeau L (2015) Elevated mitochondrial bioenergetics and axonal Arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol 25:2349\u20132360","journal-title":"Curr Biol"},{"issue":"1","key":"1926_CR298","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, D\u00e9glon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802(1):52\u201361","journal-title":"Biochim Biophys Acta"},{"key":"1926_CR299","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","volume":"218","author":"HA Elfawy","year":"2019","unstructured":"Elfawy HA, Das B (2019) Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies. Life Sci 218:165\u2013184","journal-title":"Life Sci"},{"issue":"3","key":"1926_CR300","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.gendis.2016.05.001","volume":"3","author":"J Wang","year":"2016","unstructured":"Wang J, Chen GJ (2016) Mitochondria as a therapeutic target in Alzheimer\u2019s disease. Genes Dis 3(3):220\u2013227","journal-title":"Genes Dis"},{"key":"1926_CR301","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"G Cenini","year":"2019","unstructured":"Cenini G, Voos W (2019) Mitochondria as potential targets in Alzheimer disease therapy: an update. Front Pharmacol 10:902","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"1926_CR302","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1002\/mds.22781","volume":"25","author":"B Thomas","year":"2010","unstructured":"Thomas B, Beal MF (2010) Mitochondrial therapies for Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S155\u2013S160","journal-title":"Mov Disord"},{"issue":"5","key":"1926_CR303","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","volume":"71","author":"Parkinson Study Group QE3 Investigators","year":"2014","unstructured":"Parkinson Study Group QE3 Investigators (2014) A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol 71(5):543\u2013552","journal-title":"JAMA Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01926-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-01926-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01926-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:58:56Z","timestamp":1722923936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-01926-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":303,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-01926-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}